Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
Clinical trial NCT01668797 · COMPLETED
Trial details
- NCT number
- NCT01668797
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-01-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.